Dr. William M. Scholl College of Podiatric Medicine, Rosalind Franklin University of Medicine and Science, Chicago, IL 60064, USA.
Curr Diab Rep. 2012 Oct;12(5):551-9. doi: 10.1007/s11892-012-0302-7.
Recent estimates indicate that diabetes mellitus currently affects more than 10 % of the world's population. Evidence from both the laboratory and large scale clinical trials has revealed that prolonged hyperglycemia induces chronic complications which persist and progress unimpeded even when glycemic control is pharmaceutically achieved via the phenomenon of metabolic memory. The epigenome is comprised of all chromatin modifications including post translational histone modification, expression control via miRNAs and the methylation of cytosine within DNA. Modifications of these epigenetic marks not only allow cells and organisms to quickly respond to changing environmental stimuli but also confer the ability of the cell to "memorize" these encounters. As such, these processes have gained much attention as potential molecular mechanisms underlying metabolic memory and chronic diabetic complications. Here we present a review of the very recent literature published pertaining to this subject.
最近的估计表明,目前糖尿病影响了全球超过 10%的人口。来自实验室和大规模临床试验的证据表明,长期高血糖会引起慢性并发症,即使通过药物治疗实现血糖控制,即通过代谢记忆的现象,这些并发症仍会持续存在并不受阻碍地进展。表观基因组由所有染色质修饰组成,包括翻译后组蛋白修饰、通过 miRNA 进行的表达控制以及 DNA 中胞嘧啶的甲基化。这些表观遗传标记的修饰不仅允许细胞和生物体快速响应不断变化的环境刺激,还赋予细胞“记住”这些遭遇的能力。因此,这些过程作为代谢记忆和慢性糖尿病并发症的潜在分子机制引起了广泛关注。在这里,我们对与该主题相关的最新文献进行了综述。